Bill

Bill > SB0483


MI SB0483

MI SB0483
Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.


summary

Introduced
09/12/2023
In Committee
10/04/2023
Crossed Over
10/04/2023
Passed
Dead
12/31/2024

Introduced Session

102nd Legislature

Bill Summary

A bill to provide for a cost and affordability review of certain prescription drug products; to create the prescription drug pricing board and prescription drug affordability stakeholder council and to prescribe their powers and duties; to provide for the powers and duties of certain state governmental officers and entities; to establish upper payment limits for certain prescription drug products and provide remedies; and to provide for the promulgation of rules.

AI Summary

This bill creates the Prescription Drug Cost and Affordability Review Act, which establishes a Prescription Drug Affordability Board and Stakeholder Council to review the costs and affordability of certain prescription drug products. The Board can set upper payment limits for drugs that are determined to lead to affordability challenges or high out-of-pocket costs for patients. The bill also creates a Prescription Drug Affordability Fund to fund the Board and the Department's implementation of the Act. The bill requires the Board to submit an annual report to the legislature on price trends and review activities, as well as conduct a one-time study on generic drug prices and their impact.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (18)

Last Action

Referred To Committee On Insurance And Financial Services (on 10/04/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...